Invesaro

Stocks VELO Financial statements

Financial statements

Velo3D, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Velo3D, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1927.478.777.44146
Cost of revenue12.622.577.910443.153.4
Gross profit6.374.960.84-26.3-2.09-7.4
Research and development14.22746.34215.510.7
Selling and marketing712.423.923.212.96.77
General and administrative6.3823.43741.748.430.1
Operating expenses27.662.710710776.747.5
Operating income-21.2-57.8-106-133-78.8-54.9
Interest expense0.642.740.379.72164.36
Other non-operating income0.04-0.091.450.51-3.640.53
Pre-tax income-21.8-1077.97-135-69.8-71.2
Income tax0000-0.020.12
Net income-21.8-1077.97-135-69.7-71.4
EBITDA-20-54.8-101-124-74-51.5
EPS, basic-222.51-723.1519.87-337.74-82.32-4.33
EPS, diluted-222.51-723.1519.87-337.73-82.32-4.33
Shares, basic (weighted)0.040.150.370.40.8516.5
Shares, diluted (weighted)0.040.150.410.40.8516.5

Balance sheet

FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents15.52083224.51.2139
Short-term investments015.548.26.62
Receivables1.2312.89.199.583.726.26
Inventory7.3122.571.260.85027.1
Other current assets0.819.465.5342.345.72
Total current assets27.926817211357.780.1
Property, plant and equipment1.011019.816.314.313.1
Lease right-of-use assets0.6311.113.510.78.777.63
Other non-current assets0.9316.222.717.813.510.5
Total assets32.730322315489.2105
Accounts payable1.239.8812.215.918.510.3
Accrued liabilities0.793.028.61.951.172.1
Deferred revenue4.722.315.25.1410.39.28
Short-term debt5.67
Total current liabilities12.146.746.148.73833.8
Lease liabilities0.239.1412.29.978.366.97
Other non-current liabilities-0.050.310.431.380.861.46
Total liabilities16.819284.385.549.567.2
Total debt8.36445.6731
Paid-in capital15340362425466536
Retained earnings-123-230-222-357-427-498
Other comprehensive income0-0.01-0.84-0.100
Shareholders' equity-10811013968.339.738.2
Total equity-10811013968.339.738.2
Total liabilities and equity32.730322315489.2105
Shares outstanding0.040.460.380.521324.6

Cash flow statement

FY2020FY2021FY2022FY2023FY2024FY2025
Net income-21.8-1077.97-135-69.7-71.4
Depreciation and amortization1.243.015.299.314.783.38
Stock-based compensation1.464.3720.124.911.89.51
Deferred income tax00
Change in receivables0.74-11.53.59-0.43.07-4.4
Change in inventory-2.74-8.01-4713.76.1224.4
Change in payables-0.491.882.342.21-0.74-15.3
Cash from operations-26.4-56.4-124-106-32.7-27.3
Capital expenditures-0.4-9.62-13.8-1.05-0.01-2.72
Purchases of investments0-15.5-87.7-3.660
Cash from investing-3.43-33.6-5338.97.77-2.72
Debt issued19.30
Stock issued0.050.391.260.560.320
Cash from financing35.62831.3459.31.4667.8
Exchange rate effect0-0.010.02-0.01-00.01
Net change in cash5.7193-176-7.49-23.537.8
Free cash flow-26.8-66-138-107-32.7-30
Interest paid0.461.420.379.721.181.13

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $10.97 on September 28, 2026.

Profitability

MetricValueHow it is calculated
Gross margin0.5%Gross profit / revenue.
Operating margin-86.5%Operating income / revenue.
EBITDA margin-81.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-89.6%Pre-tax income / revenue.
Net margin-89.6%Net income / revenue.
FCF margin-101.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-92.6%Cash from operations / revenue.
Return on equity (ROE)-35.2%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-25.8%Net income / average total assets.
Return on invested capital (ROIC)-61.9%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue22.6%Research and development expense / revenue.
Stock-based pay / revenue16.0%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue9.3%Capital expenditures / revenue.
D&A / revenue5.0%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y12.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-16.4%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y19.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-3.8%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-35.0%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y18.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-22.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y26.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y1,846.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y243.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y234.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio6.33xCurrent assets / current liabilities.
Quick ratio4.04x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio3.70x(Cash + short-term investments) / current liabilities.
Debt / equity0.06xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets4.1%Total debt / total assets.
Liabilities / assets26.8%Total liabilities / total assets.
Net debt-$83.0MTotal debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage-18.9xOperating income / interest expense.
Working capital$131.5MCurrent assets - current liabilities.
Tangible book value$146.5MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.29xRevenue / average total assets.
Fixed asset turnover3.56xRevenue / average property, plant and equipment.
Inventory turnover2.08xCost of revenue / average inventory.
Days inventory176 days365 x average inventory / cost of revenue.
Receivables turnover6.89xRevenue / average receivables.
Days sales outstanding53 days365 x average receivables / revenue.
Days payables33 days365 x average accounts payable / cost of revenue.
Cash conversion cycle195 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$1.75Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$1.95Revenue / diluted weighted shares.
FCF per share-$1.99Free cash flow / diluted weighted shares.
Operating cash flow per share-$1.81Cash from operations / diluted weighted shares.
Book value per share$4.56Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$4.56Tangible book value / shares outstanding.
Cash per share$2.84(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$352.7MShare price x shares outstanding.
Enterprise value$269.7MMarket cap + total debt - cash - short-term investments.
P/S6.13xMarket cap / revenue.
P/B2.41xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book2.41xMarket cap / tangible book value, when positive.
EV/Sales4.69xEnterprise value / revenue.
FCF yield-16.6%Free cash flow / market cap.
Earnings yield-14.6%Net income / market cap (the inverse of P/E).
What was Velo3D, Inc.'s revenue in fiscal 2025?

Velo3D, Inc. reported revenue of $46.0M for fiscal 2025, 12.1% higher than the year before.

Was Velo3D, Inc. profitable in fiscal 2025?

No. It reported a net loss of $71.4M.

How much free cash flow did Velo3D, Inc. generate in fiscal 2025?

Cash from operations of $27.3M minus capital expenditures of $2.7M left free cash flow of -$30.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Velo3D, Inc.